We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.21% |
| 2 | Technology | 14.44% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 8.99% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Advanced Micro Devices
AMD
$705B
| $84.6M | 0.21% |
742,674
+31,837
| +4% | +$3.31M |
|
102
Shopify
SHOP
$168B
| $83.9M | 0.21% |
1,298,005
+591
| +0% | +$33.4K |
|
103
lululemon athletica
LULU
$13.5B
| $83.8M | 0.21% |
221,470
-14,598
| -6% | -$5.39M |
|
104
Meta Platforms (Facebook)
META
$1.49T
| $83.7M | 0.21% |
291,798
+75,789
| +35% | +$18.7M |
|
105
Hershey
HSY
$37.6B
| $83.7M | 0.21% |
335,005
-11,634
| -3% | -$3.05M |
|
106
American Tower
AMT
$81.7B
| $83.1M | 0.21% |
428,473
+17,791
| +4% | +$3.48M |
|
107
Intellia Therapeutics
NTLA
$1.48B
| $82.4M | 0.2% |
2,020,079
| – | – |
|
108
Ultragenyx Pharmaceutical
RARE
$2.5B
| $82M | 0.2% |
1,776,600
-749,000
| -30% | -$34.7M |
|
109
Blue Owl Capital
OWL
$6.51B
| $81.6M | 0.2% |
7,001,000
| – | – |
|
110
Sherwin-Williams
SHW
$83.8B
| $81.1M | 0.2% |
305,499
+37,865
| +14% | +$8.91M |
|
111
Eagle Materials
EXP
$6.72B
| $80.5M | 0.2% |
432,044
-31,612
| -7% | -$5.04M |
|
112
Eaton
ETN
$142B
| $80.1M | 0.2% |
398,139
+8,201
| +2% | +$1.44M |
|
113
Freeport-McMoran
FCX
$84.7B
| $79.8M | 0.2% |
1,994,183
+482,171
| +32% | +$18.4M |
|
114
IDEAYA Biosciences
IDYA
$3.43B
| $79.7M | 0.2% |
3,389,698
+525,091
| +18% | +$10.8M |
|
115
Choice Hotels
CHH
$5.25B
| $79.1M | 0.2% |
673,017
-76,600
| -10% | -$9.2M |
|
116
Thermo Fisher Scientific
TMO
$215B
| $79.1M | 0.2% |
151,525
+5,855
| +4% | +$3.16M |
|
117
UnitedHealth
UNH
$387B
| $78.5M | 0.19% |
163,329
-4,795
| -3% | -$2.34M |
|
118
AMN Healthcare
AMN
$1.35B
| $78.3M | 0.19% |
717,755
-53,206
| -7% | -$5.04M |
|
119
CrowdStrike
CRWD
$183B
| $77.5M | 0.19% |
2,110,036
+137,544
| +7% | +$4.79M |
|
120
Palo Alto Networks
PANW
$257B
| $77.1M | 0.19% |
603,560
+316,474
| +110% | +$32.9M |
|
121
O'Reilly Automotive
ORLY
$75.2B
| $77M | 0.19% |
1,209,525
+13,365
| +1% | +$816K |
|
122
Ryman Hospitality Properties
RHP
$8.58B
| $76.6M | 0.19% |
824,023
-145,855
| -15% | -$13.4M |
|
123
Clean Harbors
CLH
$17.1B
| $76.5M | 0.19% |
464,979
-102,242
| -18% | -$14.9M |
|
124
Micron Technology
MU
$885B
| $75.8M | 0.19% |
1,201,060
-307,963
| -20% | -$19.8M |
|
125
Expedia Group
EXPE
$36.1B
| $75.4M | 0.19% |
689,285
-230,811
| -25% | -$22.6M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.